The penetrative abilities of liposomal mithramycin in explanted keloids

Clinical and Experimental Dermatology

Volumn 34, Issue 3, 2009, Pages 408-409

  Anthony, E T ^a,b   Kantaria, S ^a   Moir, G C ^b   Chopra, S ^b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DRUG VEHICLE; LIPOSOMAL MITHRAMYCIN; LIPOSOME; MITHRAMYCIN; UNCLASSIFIED DRUG;

DERMIS; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENCAPSULATION; EPIDERMIS; EXPLANT; FLUORESCENCE MICROSCOPY; HUMAN; KELOID; LETTER; LIPOSOMAL DELIVERY; PRIORITY JOURNAL; SCAR; STRATUM CORNEUM;

EPIDERMIS; HUMANS; KELOID; LIPOSOMES; PLICAMYCIN; PROTEIN SYNTHESIS INHIBITORS; SKIN ABSORPTION;

EID: 62449205655     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02901.x     Document Type: Letter

References (3)

1. Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg 2006 8 : 362 8.
2. Mutalik S. Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 2005 71 : 3 8.
3. Sandorfi N, Louneva N, Hitraya E et al. Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin. Ann Rheum Dis 2005 64 : 1685 91.